Funding for this research was provided by:
National Key Research & Development Program of China (2016YFC1307200)
Beijing municipal hospital Research and Cultivation Program (PX2018064)
Beijing Demonstrative Research Ward (Grant No. BCRW202009)
Received: 7 February 2022
Accepted: 11 April 2022
First Online: 3 May 2022
: This study is approved by the ethics review committee of the Beijing Anding Hospital (No. 2017–No. 24-201854 XG-3, Beijing, China) prior to the start of recruitment. This approval covered all trial sites. It is essential for participants to know that they can withdraw from the study at any time. The results will be disseminated via peer-reviewed publications and presentations at conferences.
: Written, informed consent to participate will be obtained from all participants.
: The authors declare that they have no competing interests.